Price
No data yet.
Social Signal Score
Analyst Ratings
Company Profile
- Sector
- Financial Services
- Industry
- Asset Management
- Beta
- 0.00
- Country
- ES
Quote
Valuation & Ratios
Returns & Efficiency
Valuation
SABhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
80-20.00%Social Signal Score
Mentions (3)
- Newsglobenewswire.com·5d ago·Negative
SAB BIO to Present SAB-142 Data at the Inaugural Breakthrough T1D Clinical & Research Congress MIAMI, Oct. 01, 2026 (GLOBE NEWSWIRE) -- SAB Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage biopharmaceutical company developing a fully human anti-thymocyte immunoglobulin (hATG) for type 1 diabetes (T1D) and other autoimmune diseases, today announced presentations at the upcoming inaugural Breakthrough T1D Clinical & Research Congress (CRC 2026) being held October 9-11, 2026 in Philadelphia, …
View source ↗ - Newsglobenewswire.com·14d ago·Negative
SAB BIO to Present SAB-142 Data at the 62nd Annual Meeting of the European Association for the Study of Diabetes MIAMI, Sept. 22, 2026 (GLOBE NEWSWIRE) -- SAB Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage biopharmaceutical company developing a fully human anti-thymocyte immunoglobulin (hATG) for type 1 diabetes (T1D) and other autoimmune diseases, today announced presentations at the upcoming 62nd Annual Meeting of the European Association for the Study of Diabetes (EASD) being held Sep…
View source ↗ - Newsglobenewswire.com·35d ago·Neutral
SAB BIO to Participate in Upcoming Investor Conferences MIAMI, Sept. 01, 2026 (GLOBE NEWSWIRE) -- SAB Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage biopharmaceutical company developing a fully human anti-thymocyte immunoglobulin (hATG) for type 1 diabetes (T1D) and other autoimmune diseases, today announced that members of its management team will participate in upcoming investor conferences in September:
View source ↗
Congress trades
No disclosed congressional trades in SAB.
Self-reported filings, amounts as brackets. Via Senate/House disclosures.